Response of the author to the letter “Cost-effectiveness study of leflunomide versus methotrexate”
Respuesta del autor a la carta «Estudio coste-efectividad de leflunomida frente a metrotexato»
Read
3419
Timeswas read the article
1748
Total PDF
1671
Total HTML
Share statistics
array:22 [ "pii" => "S2173574309701406" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70140-6" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70140" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "copyrightAnyo" => "2009" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2009;5:292-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 527 "formatos" => array:3 [ "EPUB" => 42 "HTML" => 321 "PDF" => 164 ] ] "itemAnterior" => array:18 [ "pii" => "S217357430970139X" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70139-X" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70139" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2009;5:291" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 498 "formatos" => array:3 [ "EPUB" => 37 "HTML" => 338 "PDF" => 123 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Cost-effectiveness study of leflunomide versus methotrexate" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "291" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio coste-efectividad de leflunomida frente a metotrexato" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jordi Galván" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jordi" "apellidos" => "Galván" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357430970139X?idApp=UINPBA00004M" "url" => "/21735743/0000000500000006/v1_201305061600/S217357430970139X/v1_201305061600/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Response of the author to the letter “Cost-effectiveness study of leflunomide versus methotrexate”" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "292" "paginaFinal" => "293" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Antonio J. García Ruiz, Ana C. Montesinos Gálvez, Lucía Pérez Costillas, Pablo Rebollo" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Antonio J." "apellidos" => "García Ruiz" "email" => array:1 [ 0 => "ajgr@uma.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Ana C." "apellidos" => "Montesinos Gálvez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Lucía Pérez" "apellidos" => "Costillas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Pablo" "apellidos" => "Rebollo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Unidad de Farmacoeconomía e Investigación de Resultados en Salud, Universidad de Málaga, Málaga, Spain" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "BAP Health Outcomes, Oviedo, Principado de Asturias, Spain" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta del autor a la carta «Estudio coste-efectividad de leflunomida frente a metrotexato»" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparación de leflunomida y metotrexato subcutáneo en el tratamiento de la artritis reumatoide: una aproximación basada en el número de pacientes que es necesario tratar" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.A. García Ruiz" 1 => "A.C. Montesinos Gálvez" 2 => "L. Pérez Costillas" 3 => "P. Rebollo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reuma.2008.11.007" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2009" "volumen" => "5" "paginaInicial" => "66" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794646" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Agencia de Evaluación de Tecnologías Sanitarias de Andalucía. Guía para la Incorporación de Nuevos Fármacos. Apoyo a la toma de decisiones en los hospitales del Sistema Sanitario Público de Andalucía [Internet]. Versión 2.0. Sevilla: AETSA; 2004 [consulted 6/2/2009]. Available from: URL: http://www.juntadeandalucia.es/salud/orgdep/aetsa/pdf/Guía GINF v2.pdf." ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost-efectiveness analysis based on the numberneeded- to-treat: Common sense or non-sense?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "I.S. Kristiansen" 1 => "D. Gyrd-Hansen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hec.797" "Revista" => array:6 [ "tituloSerie" => "Health Econ" "fecha" => "2004" "volumen" => "13" "paginaInicial" => "9" "paginaFinal" => "19" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14724890" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Limitaciones y falacias de la fórmula del “número de pacientes que será necesario tratar”" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E. Figueredo" 1 => "L. Canosa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1999" "volumen" => "112" "paginaInicial" => "36" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Braun" 1 => "P. Kästner" 2 => "P. Flaxenberg" 3 => "J. Währisch" 4 => "P. Hanke" 5 => "W. Demary" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.23144" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2008" "volumen" => "58" "paginaInicial" => "73" "paginaFinal" => "81" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18163521" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.K. Moitra" 1 => "J.M. Ledingham" 2 => "R.G. Hull" 3 => "F.C. McCrae" 4 => "A.L. Thomas" 5 => "R. Shaban" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/rheumatology/keh471" "Revista" => array:6 [ "tituloSerie" => "Rheumatology" "fecha" => "2005" "volumen" => "44" "paginaInicial" => "256" "paginaFinal" => "257" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15637036" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Parenteral methotrexate should be given before biological therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S.J. Bingham" 1 => "M.H. Buch" 2 => "S. Lindsay" 3 => "A. Pollard" 4 => "J. White" 5 => "P. Emery" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/rheumatology/keg246" "Revista" => array:6 [ "tituloSerie" => "Rheumatology" "fecha" => "2003" "volumen" => "42" "paginaInicial" => "1009" "paginaFinal" => "1010" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12869673" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: An evaluation based on a 1–year randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Maetzel" 1 => "V. Strand" 2 => "P. Tugwell" 3 => "G. Wells" 4 => "C. Bombardier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pharmacoeconomics" "fecha" => "2002" "volumen" => "20" "paginaInicial" => "61" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11817993" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000000500000006/v1_201305061600/S2173574309701406/v1_201305061600/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000500000006/v1_201305061600/S2173574309701406/v1_201305061600/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574309701406?idApp=UINPBA00004M" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 6 | 15 | 21 |
| 2024 October | 22 | 31 | 53 |
| 2024 September | 20 | 20 | 40 |
| 2024 August | 38 | 33 | 71 |
| 2024 July | 24 | 32 | 56 |
| 2024 June | 25 | 23 | 48 |
| 2024 May | 16 | 15 | 31 |
| 2024 April | 14 | 16 | 30 |
| 2024 March | 20 | 22 | 42 |
| 2024 February | 17 | 18 | 35 |
| 2024 January | 13 | 20 | 33 |
| 2023 December | 14 | 21 | 35 |
| 2023 November | 15 | 21 | 36 |
| 2023 October | 27 | 21 | 48 |
| 2023 September | 16 | 31 | 47 |
| 2023 August | 14 | 16 | 30 |
| 2023 July | 25 | 15 | 40 |
| 2023 June | 17 | 23 | 40 |
| 2023 May | 17 | 12 | 29 |
| 2023 April | 17 | 11 | 28 |
| 2023 March | 23 | 29 | 52 |
| 2023 February | 15 | 34 | 49 |
| 2023 January | 19 | 27 | 46 |
| 2022 December | 19 | 34 | 53 |
| 2022 November | 23 | 30 | 53 |
| 2022 October | 23 | 45 | 68 |
| 2022 September | 20 | 30 | 50 |
| 2022 August | 24 | 38 | 62 |
| 2022 July | 44 | 37 | 81 |
| 2022 June | 38 | 35 | 73 |
| 2022 May | 24 | 40 | 64 |
| 2022 April | 15 | 41 | 56 |
| 2022 March | 19 | 33 | 52 |
| 2022 February | 19 | 24 | 43 |
| 2022 January | 9 | 38 | 47 |
| 2021 December | 21 | 34 | 55 |
| 2021 November | 24 | 48 | 72 |
| 2021 October | 24 | 53 | 77 |
| 2021 September | 31 | 45 | 76 |
| 2021 August | 18 | 37 | 55 |
| 2021 July | 14 | 31 | 45 |
| 2021 June | 34 | 40 | 74 |
| 2021 May | 15 | 31 | 46 |
| 2021 April | 50 | 103 | 153 |
| 2021 March | 36 | 43 | 79 |
| 2021 February | 26 | 19 | 45 |
| 2021 January | 17 | 13 | 30 |
| 2020 December | 12 | 21 | 33 |
| 2020 November | 11 | 14 | 25 |
| 2020 October | 7 | 9 | 16 |
| 2020 September | 74 | 20 | 94 |
| 2020 August | 73 | 15 | 88 |
| 2020 July | 29 | 11 | 40 |
| 2020 June | 28 | 21 | 49 |
| 2020 May | 37 | 18 | 55 |
| 2020 April | 44 | 17 | 61 |
| 2020 March | 14 | 10 | 24 |
| 2020 January | 4 | 0 | 4 |
| 2019 September | 4 | 0 | 4 |
| 2019 June | 2 | 0 | 2 |
| 2019 March | 2 | 0 | 2 |
| 2019 January | 1 | 0 | 1 |
| 2018 May | 3 | 1 | 4 |
| 2018 April | 15 | 7 | 22 |
| 2018 March | 21 | 10 | 31 |
| 2018 February | 19 | 2 | 21 |
| 2018 January | 2 | 2 | 4 |
| 2017 December | 8 | 5 | 13 |
| 2017 November | 6 | 7 | 13 |
| 2017 October | 10 | 6 | 16 |
| 2017 September | 13 | 4 | 17 |
| 2017 August | 5 | 11 | 16 |
| 2017 July | 9 | 10 | 19 |
| 2017 June | 15 | 6 | 21 |
| 2017 May | 17 | 9 | 26 |
| 2017 April | 7 | 6 | 13 |
| 2017 March | 12 | 16 | 28 |
| 2017 February | 4 | 9 | 13 |
| 2017 January | 12 | 2 | 14 |
| 2016 December | 29 | 12 | 41 |
| 2016 November | 17 | 2 | 19 |
| 2016 October | 32 | 12 | 44 |
| 2016 September | 22 | 7 | 29 |
| 2016 August | 17 | 7 | 24 |
| 2016 July | 13 | 11 | 24 |
Show all
